Shares of Cardio Diagnostics Holdings, Inc. (CDIO), an artificial intelligence-powered precision cardiovascular medicine company, are rising nearly 150% Tuesday morning following the launch of PrecisionCHD, a blood test for the early detection of coronary heart disease.
PrecisionCHD, a non-invasive test detects coronary heart disease with better than 75% sensitivity in both men and women. the company said.
CDIO is at $3.15 currently. It has traded in the range of $0.79-$10.25 in the last 1 year.
Source: Read Full Article
Lates News:
-
"Market Manipulation?" — Former SEC Official Reveals Factors Propelling Bitcoin’s Latest Price Ascent
-
Scholastic Shares Fall 20% Following Wider Loss In Q3
-
Bitcoin: A ‘Lottery Ticket’? Ireland’s Central Bank Governor Weighs In on Crypto
-
Bitcoin to Reach $10 Million, Forecasts Investment Firm Founder Larry Lepard
-
NIKE Slides 11% As Profit Drops In Q1